Navigation Links
XTL in Medical News

Notification of Annual General Meeting and Extraordinary General Meeting

...ty's site: http://www.magna.isa.gov.il . ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007

...ital well into the first quarter of 2009." ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...he treatment of diabetic neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Announces Delisting From the Official List of the United Kingdom Listing Authority

...SDAQ, or trade their ordinary shares on the TASE. xtl Biopharmaceuticals Ltd. has further announced that...1-212-815-3004, jpaltrowitz@bankofny.com About xtl Biopharmaceuticals Ltd. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...
XTL in Medical Technology

XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma

...EHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XT...ent for a severe and incurable blood cancer. We at xtl are thrilled at this opportunity and expect to emb...ce with the terms of the asset purchase agreement, xtl will issue Bio-GAL Ltd. ordinary shares representi...

XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain

...rly await the outcome of this study in Q4 2008." xtl in-licensed the world-wide rights to Bicifadine fr..., Inc. (NASDAQ OTC: DOVP) in January 2007. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis

...gnificant side affects associated with it. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...ics for the treatment of neuropathic pain and HCV. xtl is developing Bicifadine, a serotonin and norepine...

XTL Provides Update on Phase I Clinical Trial of XTL-2125

... New York, June 06, 2007 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. announced today that it ha...rved in the placebo group. Based on these results, xtl has decided to suspend further development of XTL-...f this Phase I trial concludes our research on the xtl legacy compounds that we inherited. Through an agg...
XTL in Biological Technology

Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes

REHOVOT, Israel, March 18 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. All of the resolutions at the EGMs were passed. The current board of directors consists of Mark...

Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders' Meetings after Receipt of Shareholder Letter

VALLEY COTTAGE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XTL) today provided notification that on February 3, 2009 the Company received a letter from a shareholder who owns more than 5% of the Company's outstanding ordinary shares requesting th...

Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)

VALLEY COTTAGE, N.Y., Oct. 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announces the results of its Extraordinary General Meetings ("EGMs") held earlier today. The outcome of the EGMs was as follows: all of the resolutions passed and Jennifer L. Good ...

XTL to Appeal NASDAQ Staff Determination; XTL May Transfer its ADR Listing to the NASDAQ Capital Market

VALLEY COTTAGE, New York, September 26 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced that on September 24, 2007, the Company received a NASDAQ Staff Determination indicating that the Company fails to comply with the minimum $10 mill...

Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, New York, September 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) will hold a conference call today, September 11, 2007, at 8:30 a.m. EDT to discuss the Phase IIb clinical trial of Bicifadine for the treatment of diabetic neuropa...

XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market

NEW YORK, August 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL), a biopharmaceutical company engaged in the acquisition, development and commercialization of therapeutics for the treatment of unmet medical needs, particularly neuropathic pain and...

Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer

...f all of our stakeholders." Ron Bentsur has more than a decade of experience in the biotech industry. Most recently, Mr. Bentsur served as CEO of xtl Biopharmaceuticals, a position he held from January 2006 until April 2009. Prior to his tenure at XTL, Mr. Bentsur was with the Company from 2000-200...

XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel

...EHOVOT, Israel, April 16 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB , TASE: XT... proceed with the delisting process. ABOUT xtl BIOPHARMACEUTICALS LTD. xtl Biopharmaceuticals Ltd. ("XTL") is engaged in the ...

XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009

... VALLEY COTTAGE, N.Y., March 11 /PRNewswire-FirstCall/ -- xtl Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) announced today that its Extraordinary General Meetings ("EGMs") were postponed for one week in a...

XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors

...Mr. Shweiger received an LL.B, magna cum laude, from the College of Management and an MBA in finance and auditing from Tel - Aviv University . xtl also announced that its appeal hearing date for its Nasdaq listing has been changed to March 19, 2009 from March 12, 2009. Cautionary Statemen...
Other Tags
(Date:11/26/2014)... (PRWEB) November 26, 2014 Loffler Companies ... The Week in Imaging, an online information and news ... This is the sixth consecutive year Loffler has earned ... years. , The Elite Dealer Awards honor the best ... This year’s Elite Dealer honorees were chosen for their ...
(Date:11/26/2014)... Senior Planning Services, providing “expert guidance ... organization providing the adult demographic education and access ... navigate the rough seas of applying for Medicaid. Part ... the topic of Medicaid eligibility and proper planning, while ... applying for this coverage. , Senior Planning Services ...
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Rouge, Louisiana (PRWEB) November 26, 2014 ... neck pain relief and specialists in minimally invasive ... K. Samer Shamieh into the rapidly growing provider ... specialists. The addition coincides with the network’s ... reliable medical treatment for Louisiana residents who are ...
(Date:11/26/2014)... Youngsters who enter puberty early are at increased risk ... was linked with a number of factors associated with ... according to the researchers. Early puberty was also linked ... peers, and having friends who were prone to getting ... found an association between early puberty and these factors, ...
Breaking Medicine News(10 mins):Health News:Loffler Companies Recognized as an Elite Dealer for Sixth Consecutive Year 2Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2
(Date:11/7/2014)...  In conjunction with the Glendale ... Foundation of the Verdugos has announced the " GLENDALE ... $250,000 initiative to keep the Verdugo Regional Crime Lab operational ... months of existence, the Lab has processed more than 400 ... enforcement. "Because our number one priority is the ...
(Date:11/6/2014)... 2014 - Insilico Medicine, Inc, a Baltimore-based bioinformatics ... related diseases announced a research collaboration with the ... Oncology, Inc (OTC: CSBR). , "There are many ... but Champions Oncology,s TumorGraft technology is unique in ... regimen experimentally generating vast amounts of valuable data. ...
(Date:11/4/2014)... the right time might actually help boost a species, ... in understanding animal populations, pest control and managing fish ... journal Trends in Ecology and Evolution , a ... kind of positive population effect an overall species experiences ... the size and developmental stage of the creatures that ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
Other Contents